Rockwell Medical, Inc. (RMTI)
-NasdaqGM 3.50 
0.03(0.86%) 9:53AM EDT - Nasdaq Real Time Price
| Prev Close: | 3.47 |
|---|
| Open: | 3.44 |
|---|
| Bid: | 3.43 x 3800 |
|---|
| Ask: | 3.45 x 26400 |
|---|
| 1y Target Est: | 13.00 |
|---|
| Beta: | 0.85 |
|---|
| Next Earnings Date: | 5-Aug-13 |
|---|
| Day's Range: | 3.42 - 3.51 |
|---|
| 52wk Range: | 3.16 - 10.70 |
|---|
| Volume: | 98,299 |
|---|
| Avg Vol (3m): | 483,271 |
|---|
| Market Cap: | 90.51M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -2.82 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- InPlay: Rockwell Medical presents PRIME study results at the 50th ERA-EDTA meeting in istanbul, turkey; unique iron drug SFP Met primary endpoint demonstrating statistically significant 35% reduction in esa dose; safety profile similar to pBriefing.com(Mon 8:04AM EDT)
- Rockwell Medical Presents PRIME Study Results at the 50th ERA-EDTA Meeting in Istanbul, TurkeyMarketwired(Mon 8:00AM EDT)
- Rockwell Medical Announces the Exercise of Over-Allotment OptionMarketwired(Thu, May 16)
- ROCKWELL MEDICAL, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online(Thu, May 16)
- ACADIA Prices Public Offering and 2 Other Hot Stocks to Watchat Wall St. Cheat Sheet(Wed, May 15)
- Rockwell Medical prices $35M stock offeringAP(Wed, May 15)
- Rockwell Medical Prices $35.0 Million Public Offering of Common StockGlobeNewswire(Wed, May 15)
- ROCKWELL MEDICAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and ExhibEDGAR Online(Wed, May 15)
- 4 Healthcare Stock Stories For Tuesday Investment Wellnessat Wall St. Cheat Sheet(Tue, May 14)
- Rockwell Medical Announces Proposed Public Offering of Common StockGlobeNewswire(Tue, May 14)
- ROCKWELL MEDICAL, INC. FinancialsEDGAR Online Financials(Tue, May 14)
- ROCKWELL MEDICAL, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online(Tue, May 14)
- ROCKWELL MEDICAL, INC. Files SEC form 8-K, Entry into a Material Definitive AgreementEDGAR Online(Thu, May 9)
- Rockwell Medical Management Discusses Q1 2013 Results - Earnings Call Transcriptat Seeking Alpha(Wed, May 8)
- Rockwell Medical Announces Long-Term, National Supply Agreement With DaVitaGlobeNewswire(Wed, May 8)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | 1.79 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -1.72 |
|---|
| Quarterly EPS Est
(Jun-13)
: | -0.45 |
|---|
| Mean Recommendation*: | 1.0 |
|---|
| PEG Ratio (5 yr expected): | -0.03 |
|---|
Business Summary
Rockwell Medical, Inc. operates as an integrated biopharmaceutical company in the United States and internationally. The company offers products and services for the treatment of end-stage renal disease, chronic kidney disease (CKD), iron deficien...
View More